Friday 6 November 2026 Export ALNY’s income statement to Excel — free account

Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.7 billion, up 65.2% from fiscal 2024.

Revenue: +16.7%
EPS: +747.6%
Free cash flow: −4.76%
Total debt: −2.66%

Quarter to September 2026, against a year earlier

156.54 0.12 −0.08%

Follow ALNY

Alert me

Market cap: $21.0B
P/E: 7.9×
Fwd P/E: 13.5×
Dividend yield: —
F-score: 6/9
Altman Z: 7.30
Beneish M: −1.95
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
P/E ratio Full definition →	12.46	54.44	87.30	189.42	+8 more quarters Free account
P/S ratio Full definition →	6.59	8.37	10.26	14.16
P/FCF ratio Full definition →	40.95	49.06	68.35	112.99
P/Operating CF Full definition →	96.84	123.10	623.66	241.50
P/B ratio Full definition →	9.16	29.70	40.89	66.63
Price to Tangible BV Full definition →	9.16	29.70	40.89	66.63
EV/Sales Full definition →	6.07	7.89	9.79	13.65
EV/EBITDA Full definition →	29.47	35.96	52.01	90.95
EV/Operating CF Full definition →	31.85	41.59	58.71	96.71
EV/FCF Full definition →	37.76	46.25	65.24	108.90
Quick Ratio Full definition →	2.26	2.79	2.89	2.51
Current Ratio Full definition →	2.48	3.05	3.13	2.76
Net Debt/EBITDA Full definition →	(7.15)	(9.36)	(7.09)	(13.09)
Debt/Assets Full definition →	12.67%	18.19%	19.68%	20.29%
Debt/Equity Full definition →	0.28	0.75	0.94	1.28
Asset Turnover Full definition →	0.78	0.95	0.92	0.81
Operating CF/Net income Full definition →	0.16	1.99	0.34	1.95
Capex/Depreciation Full definition →	(4.82)	(2.50)	(1.61)	(1.72)
Interest Coverage Full definition →	4.10	2.82	3.88	2.01
Research and Development Expense of Revenue Full definition →	28.02%	32.00%	31.26%	33.93%
Selling, General and Administrative Expense of Revenue Full definition →	23.46%	26.95%	27.64%	29.66%
Intangible Assets out of Total Assets Full definition →	0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →	5.43%	6.71%	6.01%	6.53%
Graham Net Nets Full definition →	0.02	0.01	0.00	0.00
Graham Number Full definition →	109.56	35.51	26.27	16.79
Earnings Yield Full definition →	8.03%	1.84%	1.15%	0.53%
Free Cash Flow Yield Full definition →	2.44%	2.04%	1.46%	0.89%
Revenue per Share Full definition →	10.90	9.66	8.78	8.30
Operating CF per Share Full definition →	2.55	2.45	0.53	1.65
Capex per Share Full definition →	(0.52)	(0.26)	(0.16)	(0.18)
Free Cash Flow per Share Full definition →	2.03	2.19	0.37	1.47
Cash per Share Full definition →	26.81	24.76	22.64	22.00
Shareholders Equity per Share Full definition →	26.93	10.14	8.09	5.97
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	26.93	10.14	8.09	5.97
Free Cash Flow Full definition →	271.15	292.04	48.67	194.44
Working Capital Full definition →	3,049.66	3,107.66	2,869.83	2,584.31
Capital Expenditures Full definition →	(69.83)	(34.68)	(21.83)	(23.29)
Net Current Asset Value Full definition →	721.84	415.52	165.14	(126.49)
EV/EBIT Full definition →	31.14	37.93	55.80	101.04
Capex to Sales Full definition →	0.05	0.03	0.02	0.02
Price to Operating Income Full definition →	33.78	40.23	58.46	104.83
Other line items
Average Receivables Full definition →	1,024.84	739.93	651.00	591.44
Average Payables Full definition →	126.50	105.20	112.01	102.07
Average Inventory Full definition →	90.65	84.40	74.80	80.61
Average Assets Full definition →	6,423.17	5,062.39	4,671.68	4,603.16
Average Common Equity Full definition →	1,918.87	802.35	595.41	428.13

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly